$45.06
$0.71
(1.60%)
Quote as of 4:00 PM EST on 02/09/12
GlaxoSmithKline
NYSE:GSK
|
$45.06
$0.71
(1.60%)
|
|
| Today's Open | $44.90 |
|---|---|
| Previous Close | $44.35 |
| Daily Range | $44.71 - $45.14 |
| 52-Week Range | $36.39 - $46.50 |
| Market Cap | $113.81B |
| P/E Ratio | 44.80 |
| Dividend (Yield) | $2.17 (5.1%) |
| Ex-Dividend Date Dividend Pay Date |
02/15/12 04/12/12 |
| Volume | 3,005,912 |
| Average Daily Volume | 2,304,348 |
| Current FY EPS | $3.52 |
GSK Information
| Description |
|---|
| The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. |
| Sector |
| Healthcare |
| Industry |
| Pharmaceuticals |
News & Commentary
How the Wheels Came off GlaxoSmithKline's Bus
Vodafone Reviewing Billing Systems In Case Of Eurozone Shake Up
Speedy Review for Roche Drug - Analyst Blog
GlaxoSmithKline Buys Back 425,000 Shares
Glaxo Misses Estimates by a Mile - Analyst Blog
ChemoCentryx IPO Up 12% After Cutting Price
Is Avanir Pharmaceuticals the Perfect Stock?
Amgen Upped to Outperform - Analyst Blog
GlaxoSmithKline Buys Back 575,000 Shares
CIVETS Watch: US Dollar Is Popular in Egypt, but US Is Not
